Leonard Henry, MD
Surgical Oncology · Savannah, GANPI 1992704449
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $398 of the $467 with a category attached, or 85.3%. 4 manufacturers reported payments, led by Tempus AI, Inc at 39.5% of the total. 2025 is the largest year on record at $193, 2.8 times the $70 reported in 2021. That places this record below the midpoint for surgical oncology clinicians in GA, where the typical reported total is $2,336.
Across 5 payments — averaging $93.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tempus AI, Inc$184
- Medtronic$144
- Novocure Inc.$70
- AstraZeneca$68
Across 1 payment — averaging $102,712 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$103K
What the payments were for
- Food & beverage$39885%
- Education$6815%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tempus AI, Inc | 2 | $184 |
| Medtronic | 1 | $144 |
| Novocure Inc. | 1 | $70 |
| AstraZeneca | 1 | $68 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$467 in reported general payments places this provider in the 25th percentile of 43 surgical oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Savannah
- James GarberSavannah$7K
- William BurakSavannah$2K
- Howard ZarenSavannah$0
- Eddie AbdallaAtlanta$34K
- Atuhani BurnettAtlanta$23K
- Anita JohnsonWoodstock$18K
- Danny YakoubAugusta$17K
- Nicole KounalakisAtlanta$14K
- Sartaj SangheraMarietta$10K
- Barry RosemanAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.